Correlation Between 23Andme Holding and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Mereo BioPharma Group, you can compare the effects of market volatilities on 23Andme Holding and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Mereo BioPharma.
Diversification Opportunities for 23Andme Holding and Mereo BioPharma
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Mereo is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Mereo BioPharma go up and down completely randomly.
Pair Corralation between 23Andme Holding and Mereo BioPharma
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Mereo BioPharma. In addition to that, 23Andme Holding is 1.46 times more volatile than Mereo BioPharma Group. It trades about -0.07 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.1 per unit of volatility. If you would invest 124.00 in Mereo BioPharma Group on September 12, 2024 and sell it today you would earn a total of 262.00 from holding Mereo BioPharma Group or generate 211.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Mereo BioPharma Group
Performance |
| Timeline |
| 23Andme Holding |
| Mereo BioPharma Group |
23Andme Holding and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Mereo BioPharma
The main advantage of trading using opposite 23Andme Holding and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| 23Andme Holding vs. Personalis | 23Andme Holding vs. Natera Inc | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Castle Biosciences |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets |